Increased T-regulatory cell activity drives tumor progression in the compound APC/enterotoxic colon cancer model. At the same time, how microbially-induced inflammation promotes T-regulatory cell expansion in the dysplastic intestine remains poorly described. Analysis of post-infection immune cell kinetics in the colon lamina propria revealed that CD4+ Foxp3+ cell numbers increased by 25-fold between days 3-14. Importantly, T-regulatory cell expansion was preceded by a 12-fold spike in lamina propria CD11b cell numbers between days 0-4; suggesting a link between the myeloid compartment and the T-regulatory cells. Consistent with this notion, co-culture studies utilizing sorted myeloid cell subsets and CD4 T-cells demonstrated that the CD11bCX3CR1 but not the CD11bCX3CR1 subset preferentially induced Foxp3 expression in CD4 T-cells. Phenotypic analysis revealed that the CD11bCX3CR1 subset represented a homogenous CD64CD24CD103a macrophage population. Global CX3CR1 knockout or conditional depletion of CX3CR1 myeloid cells resulted in diminished CD4Foxp3 cell expansion and a 3 to 6-fold reduction in tumor burden establishing CX3CR1 macrophages as a major driver of the T-regulatory cell-tumor axis. Quantitative analysis of CD11b myeloid cell subsets for IFNβ mRNA revealed that the CX3CR1 macrophages expressed 15-fold higher levels of IFNβ in comparison to the CX3CR1 myeloid subset. Antibody mediated neutralization of IFNβ resulted in the suppression of CD4Foxp3 cell induction and tumor growth, demonstrating the central role of IFNβ in mediating CX3CR1 macrophage-driven T-regulatory cell expansion. These studies shed new mechanistic light on the cellular ontogeny of pro-tumorigenic T-regulatory cells in the inflamed colon of the APC mouse.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844303 | PMC |
http://dx.doi.org/10.1080/2162402X.2019.1665975 | DOI Listing |
Am J Clin Exp Immunol
December 2024
Department of Surgery, Medical Faculty, Trakia University Stara Zagora, Bulgria.
Tertiary lymphoid structures (TLS), formerly recognized as Crohn's-like structures, serve as crucial biomarkers for evaluating the progression of colorectal cancer (CRC). Understanding their spatial distribution, cellular composition, and interactions within CRC is paramount for comprehending the immune response in the tumor microenvironment (TME). TLS are comprised of a T-cellular compartment and a B-cellular compartment, the latter encompassing follicular dendritic cells (FDCs), high endothelial venules (HEVs), and lymphatic vessels.
View Article and Find Full Text PDFCurr Vasc Pharmacol
January 2025
Unit of Cardiovascular Diseases, Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", Bari, Italy.
Background: Cardioimmunology is an emerging branch of medicine whose development has been facilitated by more sophisticated diagnostic procedures. Recent studies have mainly focused on the immune response during myocardial infarction (MI), and there is evidence that both resident and external immune cells participate in acute inflammatory disease, as well as tissue remodeling. Cardiac Innate Immune Cells: Following MI, macrophages, dendritic cells (DCs) and mast cells (MCs) are the main players in the heart.
View Article and Find Full Text PDFGastro Hep Adv
September 2024
Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.
Background And Aims: Refractory celiac disease type II (RCDII) is characterized by a clonally expanded aberrant cell population in the small intestine. The role of other tissue-resident immune subsets in RCDII is unknown. Here, we characterized CD8 and CD4 T cells in RCDII duodenum at the single-cell level and .
View Article and Find Full Text PDFDermatol Ther (Heidelb)
January 2025
Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, Ancona, Italy.
Introduction: Psoriasis is characterized by aberrant keratinocyte activity and immune cell infiltration, driven by immune-mediated pathways. MicroRNAs (miRNAs) play crucial roles in regulating these processes, offering insights into disease mechanisms and therapeutic targets.
Objectives: This study aimed to investigate changes in circulating miRNAs in psoriasis patients undergoing risankizumab therapy, an anti-IL-23 monoclonal antibody, to understand its impact on disease pathogenesis and treatment response.
J Immunother Cancer
January 2025
Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
Purpose: Anti-programmed cell death 1 (PD1) is the first-choice treatment in patients with advanced cutaneous squamous cell carcinoma (cSCC), when curative options are unavailable. However, reliable biomarkers for patient selection are still lacking.
Experimental Design: In this translational study, clinical annotations, tissue and liquid biopsies were acquired to investigate the association between sustained objective responses and transcriptional profiles, immune cell dynamics in tumor tissue and peripheral blood samples, as well as circulating cytokine levels.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!